This is the authors' abstract. We don't add key points for this paper.
Epstein-Barr virus (EBV) has established lifelong infection in more than 90% of humanity. While infection is usually controlled by the immune system, the human host fails to completely eliminate the pathogen. Several herpesviral proteins are known to act as immunoevasins, preventing or reducing recognition of EBV-infected cells. Only recently were microRNAs of EBV identified to reduce immune recognition further. This Gem summarizes what we know about immunomodulatory microRNAs of herpesviruses.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Albanese et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: